MI Profile
Caris tissue comprehensive molecular profiling service integrating WES, WTS, protein biomarkers and selected AI signatures for solid tumors.
- Developer
- Caris Life Sciences
- Intended use
- Other
- Cancer scope
- Not reported
- Specimen
- FFPE tumor tissue
- Molecular modality
- DNA mutation, Protein, RNA expression
- Current version
- MI Profile current integrated profiling service (2026)
- Evidence context
- 0 structured studies · 0 indexed performance results · 1 sources
Why can reported performance numbers differ? MDI keeps each result attached to its study, population, stage or stratum, test version and source rather than treating performance as a fixed property of the test.